Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study

INTRODUCTION: Immunization of patients with chronic lymphocytic leukemia (CLL) with vaccines against several infectious diseases has proven insufficient. Data on seroconversion of patients with CLL after vaccination against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) are still young...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamantopoulos, Panagiotis T., Stafylidis, Christos, Vlachopoulou, Dimitra, Kontandreopoulou, Christina-Nefeli, Giannakopoulou, Nefeli, Vardaka, Maria, Mpouhla, Anthi, Mastrogianni, Elpida, Variami, Eleni, Galanopoulos, Athanasios, Pappa, Vasiliki, Psichogiou, Mina, Hatzakis, Angelos, Viniou, Nora-Athina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131386/
https://www.ncbi.nlm.nih.gov/pubmed/35646300
http://dx.doi.org/10.1177/20406207221090150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131386/
https://www.ncbi.nlm.nih.gov/pubmed/35646300
http://dx.doi.org/10.1177/20406207221090150

Ejemplares similares